Cellectar Biosciences, Inc. (CLRB)
1.01
-0.13
(-11.40%)
USD |
NASDAQ |
Nov 16, 16:00
1.00
-0.01
(-0.99%)
After-Hours: 20:00
Cellectar Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2011 | -12.17K% |
| December 31, 2010 | -7.20K% |
| September 30, 2010 | -14.77K% |
| June 30, 2010 | -17.24K% |
| March 31, 2010 | |
| December 31, 2009 | -66.63K% |
| September 30, 2009 | -20.02K% |
| June 30, 2009 | -15.04K% |
| March 31, 2009 | -5.85K% |
| December 31, 2008 | -5.88K% |
| September 30, 2008 | -7.14K% |
| June 30, 2008 | -10.23K% |
| Date | Value |
|---|---|
| March 31, 2008 | -85.56K% |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | |
| December 31, 2005 | |
| September 30, 2005 | -7.58K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Legend Biotech Corp. | 14.38% |
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -169.4% |
| Return on Assets | -120.7% |
| Return on Invested Capital | -158.2% |
| Return on Net Operating Assets | -1.82K% |